106 patents currently held

2 more in force are now held by other companies

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

2 more records may belong here and await a decision; they are not counted.

The next term ends in Jan 2027. from the record

Free plan: 3 watched companies. Pro: unlimited.

Alerts on its grants, lapses and transfers.

Ending by 2030

Jan 2027

Next term end

Patent families

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

2026202720282029 2030 2031 203220332034 2035 2036 2037 2038 2039 204020412042 204320442045

notable patents fee due within 90 days all others Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank

Notable

Methods for Non-Invasive Prenatal Ploidy Calling US 10,017,812

Cited by 320 later US patents, top 1% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2032. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.

Ends no later than Jan 2032 · Medium confidence Also notable

Compositions and Methods for Identifying Nucleic Acid Molecules US 11,530,442

Cited by 76 later US patents, top 1% of utility patents granted in 2022 in our data. Protection runs to 2036. A terminal disclaimer caps this term to an earlier patent's.

Ends Dec 2036 · High confidence Also notable

Methods for Non-Invasive Prenatal Ploidy Calling US 9,228,234

Cited by 207 later US patents, top 5% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2029. A terminal disclaimer caps this term to an earlier patent's.

Ends Mar 2029 · Medium confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Dec 11, 2026
The maintenance fee for Methods for Simultaneous Amplification of Target Loci (US 10,316,362) comes due Dec 11, 2026. Unpaid by Jun 11, 2027, it lapses early.
1 fee due Jan 16, 2027
The maintenance fee for Methods for Simultaneous Amplification of Target Loci (US 10,351,906) comes due Jan 16, 2027. Unpaid by Jul 16, 2027, it lapses early.
1 fee due Mar 5, 2027
The maintenance fee for Methods for Amplification of Cell-Free DNA Using Ligated Adaptors and Universal and Inner Target-Specific Primers for Multiplexed Nested PCR (US 11,746,376) comes due Mar 5, 2027. Unpaid by Sep 7, 2027, it lapses early.
1 fee due Apr 20, 2027
The maintenance fee for Methods for Non-Invasive Prenatal Ploidy Calling (US 9,163,282) comes due Apr 20, 2027. Unpaid by Oct 20, 2027, it lapses early.
1 fee due Jun 30, 2027
The maintenance fee for Methods for Non-Invasive Prenatal Ploidy Calling (US 10,522,242) comes due Jun 30, 2027. Unpaid by Jan 3, 2028, it lapses early.
4 fees due Jul 5 to 21, 2027 · next Jul 5
1 fee due Aug 11, 2027
The maintenance fee for Methods for Simultaneous Amplification of Target Loci (US 10,557,172) comes due Aug 11, 2027. Unpaid by Feb 11, 2028, it lapses early.
8 fees due Sep 3 to 26, 2027 · next Sep 3
1 fee due Oct 2, 2027
The maintenance fee for Methods and Compositions for Determining Ploidy (US 11,946,101) comes due Oct 2, 2027. Unpaid by Apr 3, 2028, it lapses early.
1 fee due Nov 10, 2027
The maintenance fee for Methods for Non-Invasive Prenatal Ploidy Calling (US 9,334,541) comes due Nov 10, 2027. Unpaid by May 10, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

8 of the patents on this record were granted since Aug 16, 2026
1 term has ended since Aug 16, 2026

What they patent

The 5 largest of its 19 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Method for Determining the Number of Copies of a Chromosome in the Genome of a Target Individual Using Genetic Data from Genetically Related Individuals	74 in force	to Nov 2037
Compositions and Methods for Identifying Nucleic Acid Molecules	6 in force	to Mar 2038
Methods for Non-Invasive Prenatal Ploidy Calling	5 in force	to Oct 2031
Methods and Compositions for Determining Ploidy	3 in force	to Dec 2038
Materials and Methods for Processing Blood Samples	2 in force	to Dec 2040

Patents held now

Soonest term end first.

Patent	Title	Status	Expires	Confidence
US 10,227,652	System and Method for Cleaning Noisy Genetic Data from Target Individuals Using Genetic Data from Genetically Related Individuals In force Term ends Jan 21, 2027 · Low confidence	In force	Term ends Jan 21, 2027	Low confidence
US 10,240,202	System and Method for Cleaning Noisy Genetic Data from Target Individuals Using Genetic Data from Genetically Related Individuals In force Term ends Jan 21, 2027 · Medium confidence	In force	Term ends Jan 21, 2027	Medium confidence
US 8,024,128	System and Method for Improving Clinical Decisions by Aggregating, Validating and Analysing Genetic and Phenotypic Data In force Term ends Sep 11, 2027 · High confidence	In force	Term ends Sep 11, 2027	High confidence
US 8,515,679	System and method for cleaning noisy genetic data and determining chromosome copy number In force Term ends Mar 12, 2029 · Medium confidence	In force	Term ends Mar 12, 2029	Medium confidence
US 8,825,412	Methods for Non-Invasive Prenatal Ploidy Calling In force Term ends Mar 12, 2029 · Medium confidence	In force	Term ends Mar 12, 2029	Medium confidence
US 8,949,036	Methods for Non-Invasive Prenatal Ploidy Calling In force Term ends Mar 12, 2029 · Medium confidence	In force	Term ends Mar 12, 2029	Medium confidence
US 9,163,282	Methods for Non-Invasive Prenatal Ploidy Calling In force Term ends Mar 12, 2029 · Medium confidence	In force	Term ends Mar 12, 2029	Medium confidence
US 9,228,234	Methods for Non-Invasive Prenatal Ploidy Calling In force Term ends Mar 12, 2029 · Medium confidence	In force	Term ends Mar 12, 2029	Medium confidence
US 9,334,541	Methods for Non-Invasive Prenatal Ploidy Calling In force Term ends Mar 12, 2029 · High confidence	In force	Term ends Mar 12, 2029	High confidence
US 10,061,889	Methods for Non-Invasive Prenatal Ploidy Calling In force Term ends Mar 12, 2029 · High confidence	In force	Term ends Mar 12, 2029	High confidence

10 of 106 patents shown.

Pro members see all 106.

Pro members: see all 106 patents

Also on record, not counted in the 106: 2 patents in force now held by others · 23 patents ended · 67 applications pending · 82 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built

Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.

Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Natera, Inc.